In the present study, we found that RUVBL2 mRNA was upregulated in HCC tissues, and promoter hypomethylation, copy number gain, MYC amplification and CTNNB1 mutation all contributed to its deregulation. This evidence concerns the gene RUVBL2 and hepatocellular carcinoma.